News

May 11, 2016

BioTelemetry, Inc. Announces the Completion of Its Acquisition of VirtualScopics, Inc.

MALVERN, Pa., May 11, 2016 (GLOBE NEWSWIRE) — BioTelemetry, Inc. (NASDAQ:BEAT), the leading wireless medical technology company focused on the delivery of health information to improve quality of life and reduce cost of care, announced today that it has completed its acquisition of VirtualScopics, Inc. (NASDAQ:VSCP), a leading provider of clinical trial imaging solutions. The […]

Read More
Apr 26, 2016

BioTelemetry, Inc. Reports First Quarter 2016 Financial Results

MALVERN, Pa., April 26, 2016 (GLOBE NEWSWIRE) — BioTelemetry, Inc. (NASDAQ:BEAT), the leading wireless medical technology company focused on the delivery of health information to improve quality of life and reduce cost of care, today reported results for the first quarter ended March 31, 2016.

Read More
Mar 25, 2016

BioTelemetry, Inc. Signs Definitive Agreement to Acquire VirtualScopics, Inc.

MALVERN, PA and ROCHESTER, NY – March 25, 2016 – BioTelemetry, Inc. (NASDAQ:BEAT), the leading wireless medical technology company focused on the delivery of health information to improve quality of life and reduce cost of care, and VirtualScopics, Inc. (NASDAQ: VSCP), a leading provider of clinical trial imaging solutions, announced today that the two companies […]

Read More

Publications

May 13, 2015

Blood Pressure Evaluation During Early Phase Trials

Daniel B. Goodman, MD, Michael A. Weber, MD; 3 Nov 2014

More attention is being paid to blood pressure (BP) effects in new chemical entities under development for non-hypertension indications, especially when these are not anticipated and not thoroughly defined during drug development.

Mar 25, 2015

ECHO Inter/Intra-Reader Variability

Goodman DB and Voloshko P; 4 Sep 2014

This report by Daniel B. Goodman, MD, and Polina Voloshko, MD, of BioTelemetry Research, formerly Cardiocore, describes the inter-reader and intra-reader variability in a central reference laboratory for 8 ECHO Cardiogram (ECHO) parameters.

Aug 3, 2014

Effect of Anagrelide on Cardiac Repolarization in Healthy Volunteers: A Randomized, Double-Blind, Placebo- and Positive-Controlled, Thorough QT Study

Troy S et al; 3 Aug 2014
Dec 23, 2013

Loxapine Delivered as a Thermally Generated Aerosol Does Not Prolong QTc in a Thorough QT/QTc Study in Healthy Subjects

Spyker DA, Voloshko P, Heyman ER, Cassella JV; 23 Dec 2013
Jun 5, 2013

Association of Segmental Wall Motion Abnormalities Occurring During Hemodialysis with Post-Dialysis Fatigue

Dubin RF, et al; 5 Jun 2013
Apr 23, 2012

Major Cardiotoxicity Biomarkers During Oncology Development

Voloshko P, McPhillips J; 23 Apr 2012

Webinars

Events

Jun 3-7, 2016

ASCO

Chicago, IL
Booth #19024

Jun 26-30, 2016

DIA 2016

Philadelphia, PA
Booth #905